Cyclacel Pharmaceuticals (CYCC) Institutional Ownership $0.30 -0.01 (-2.22%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Cyclacel Pharmaceuticals (NASDAQ:CYCC)CurrentInstitutional OwnershipPercentage23.58%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$217.08KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$20.97K Get CYCC Insider Trade Alerts Want to know when executives and insiders are buying or selling Cyclacel Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CYCC Institutional Buying and Selling by Quarter Remove Ads Cyclacel Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2024 Armistice Capital LLC134,000$217K0.0%N/A9.178% 5/10/2024 Acadian Asset Management LLC14,285$29K0.0%-41.0%1.084% 11/1/2022 Kestra Advisory Services LLC23,000$34K0.0%N/A0.183% 10/25/2022Raymond James Financial Services Advisors Inc.20,806$30K0.0%-32.5%0.166% 10/18/2022 McIlrath & Eck LLC26,342$38K0.0%N/A0.210% 8/15/2022 Sio Capital Management LLC454,355$491K0.2%+7.5%4.546% 2/10/2022 Acadian Asset Management LLC23,242$89K0.0%N/A0.233% 11/16/2021 Two Sigma Advisers LP121,500$640K0.0%+929.7%1.316% 11/15/2021 Pura Vida Investments LLC105,141$554K0.0%-33.2%1.139% 11/15/2021 Tri Locum Partners LP522,943$2.76M1.1%+66.9%5.663% Get the Latest News and Ratings for CYCC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/12/2021 Affinity Asset Advisors LLC400,000$2.11M0.5%+5.3%4.332% 11/2/2021Raymond James Financial Services Advisors Inc.10,006$53K0.0%-83.3%0.108% 10/15/2021NEXT Financial Group Inc14,752$77K0.0%+70.0%0.160% 8/18/2021 Ikarian Capital LLC100,000$593K0.0%-66.7%1.083% 8/17/2021 Boothbay Fund Management LLC10,545$62K0.0%-66.7%0.114% 8/17/2021 Citadel Advisors LLC250,797$1.49M0.0%-14.7%2.716% 8/16/2021 Tri Locum Partners LP313,331$1.86M0.6%+6.8%3.393% 8/16/2021 Schonfeld Strategic Advisors LLC102,525$607K0.0%-25.0%1.110% 8/16/2021 Maven Securities LTD234,500$1.43M0.1%-6.2%2.540% 8/13/2021 Northern Trust Corp14,957$89K0.0%N/A0.162% 8/13/2021 Geode Capital Management LLC50,860$301K0.0%+143.3%0.551% 8/13/2021 Vanguard Group Inc.327,658$1.94M0.0%+9.2%3.548% 7/31/2021NEXT Financial Group Inc8,680$51K0.0%N/A0.094% 5/19/2021 Virtu Financial LLC13,108$93K0.0%+27.3%0.142% 5/19/2021 Squarepoint Ops LLC23,836$169K0.0%N/A0.258% 5/18/2021 Point72 Asset Management L.P.230,000$1.64M0.0%N/A2.491% 5/18/2021 Verition Fund Management LLC116,674$830K0.0%N/A1.264% 5/18/2021 Morgan Stanley100,000$711K0.0%-13.0%1.083% 5/18/2021 Citadel Advisors LLC293,867$2.09M0.0%N/A3.182% 5/18/2021 Silverarc Capital Management LLC250,000$1.78M1.0%N/A2.707% 5/17/2021 Schonfeld Strategic Advisors LLC136,725$972K0.0%N/A1.481% 5/17/2021 Sphera Funds Management LTD.508,322$3.61M0.3%N/A5.505% 5/17/2021 Ikarian Capital LLC300,000$2.13M0.1%-23.4%3.249% 5/12/2021 Geode Capital Management LLC20,904$148K0.0%N/A0.226% 5/12/2021 Pura Vida Investments LLC273,958$1.95M0.1%-42.3%2.967% 5/11/2021 Acadian Asset Management LLC34,057$242K0.0%N/A0.369% 4/12/2021 Valeo Financial Advisors LLC4,500$32K0.0%N/A0.063% 2/24/2021 Virtu Financial LLC10,293$80K0.0%N/A0.212% 2/12/2021Raymond James Financial Services Advisors Inc.57,006$445K0.0%+24.6%1.172% (Data available from 1/1/2016 forward)Remove Ads CYCC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CYCC shares? During the previous two years, the following institutional investors and hedge funds held shares of Cyclacel Pharmaceuticals shares: Armistice Capital LLC ($217K), Acadian Asset Management LLC ($29K).Learn more on CYCC's institutional investors. What percentage of Cyclacel Pharmaceuticals stock is owned by institutional investors? 23.58% of Cyclacel Pharmaceuticals stock is owned by institutional investors. Learn more on CYCC's institutional investor holdings. Which institutional investors have been buying Cyclacel Pharmaceuticals stock? The following institutional investors have purchased Cyclacel Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($134K). How much institutional buying is happening at Cyclacel Pharmaceuticals? Institutional investors have bought a total of 134,000 shares in the last 24 months. This purchase volume represents approximately $217.08K in transactions. Which Cyclacel Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Cyclacel Pharmaceuticals stock in the last 24 months: Acadian Asset Management LLC ($9.94K). How much institutional selling is happening at Cyclacel Pharmaceuticals? Institutional investors have sold a total of 9,938 shares in the last 24 months. This volume of shares sold represents approximately $20.97K in transactions. Related Companies Aytu BioPharma Institutional Ownership Creative Medical Technology Institutional Ownership BioXcel Therapeutics Institutional Ownership Organovo Institutional Ownership Bright Green Institutional Ownership Omega Therapeutics Institutional Ownership Cyclerion Therapeutics Institutional Ownership Sonoma Pharmaceuticals Institutional Ownership NKGen Biotech Institutional Ownership GT Biopharma Institutional Ownership This page (NASDAQ:CYCC) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredRevealed: The Chip Stock Redefining AI as We Know ItIn this urgent presentation, Wall Street's so-called "AI Oracle" unveils the name of a small American tech fir...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclacel Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyclacel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CYCC Stock Free CYCC Stock Alerts